FDA Offers New Guidelines for COVID Vaccine

An FDA expert panel recommended the fall Covid booster shots should target the JN.1 subvariant, from which KP.2 derives. Pfizer and Moderna indicated that they could make shots targeting either version of the virus, and still deliver their doses in August.